Dietary modifications can help manage gastrointestinal side effects
Find articles by Momen, A
Rapid weight loss may be associated with loss of lean muscle mass, and this warrants monitoring
Studies have shown that simultaneous blockade of both activin A and MSTN, both ligands of ActRIIA/B, produces greater increases in muscle mass than inhibiting either alone.[82] This finding is supported by clinical trials, where combined treatment with trevogrumab (anti-MSTN) and garetosmab (anti-activin A) increased total body muscle volume and reduced fat mass compared with placebo or either antibody alone.[83] Overall, activin A inhibitors are as promising as MSTN inhibitors, and their combination may yield superior outcomes
The result is a solution of known concentration, expressed in milligrams per millilitre (mg/mL)
While probiotics have a generally favorable safety profile, individual reactions vary